Skip to content

Clinical trials

Phase 2 Proteinuria trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Proteinuria Phase: Phase 2 Country / region: Canada Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20111
20133
20171
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
AbbVie (prior sponsor, Abbott)1
Calliditas Therapeutics AB1
GlaxoSmithKline1
Hiddo Lambers Heerspink1
Mayo Clinic1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Proteinuria9
Diabetes Mellitus2
Hyperlipidemias2
Renal Insufficiency, Chronic2
Albuminuria1
Autoimmune Diseases1
Diabetes Mellitus, Type 21
Diabetic Nephropathies1
Glomerulonephritis1
Glomerulonephritis, IGA1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.